mounjaro tirzepatide news today september 2025 Republican Administration Maintains Exclusivity Stance in GLP-1 (Tirzepatide) Compounding Dispute Eli Lilly’s diabetes & weight-loss

Description

"Zenagamtide (amycretin), a novel unimolecular GLP-1 and amylin receptor agonist: phase 2b results in T2D." Poster presentation, American Diabetes Association Scientific Sessions, June 2026

Unlike some compounded regimens that allow for flexible or micro-dosed schedules, FDA-approved GLP-1s have specific dosing timelines (usually weekly)

Where should I keep my Semaglutide medication

Its dual agonism and extended half-life provide a robust platform for exploring innovative treatments, making it an essential tool for advancing scientific discovery in metabolic and endocrine research

Marshall Silverman, MD, a board-certified internal medicine specialist with over two decades of experience in Charlotte, combines his clinical role with academic pursuits as a clinical associate professor at UNC-Chapel Hill